• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Partnership will see Amazon Alexa provide access to NHS-verified health information

Share:

July 16, 2019

After the formal launch of NHSX, a new unit for digital, data and technology, the department of health and social care in England has announced that the NHS is working with Amazon to offer access to verified health information to people through the AI-powered voice assistant Alexa.

Amazon’s algorithms will use information from the NHS Choices resource, providing answers to questions about symptoms of common illnesses, such as flu and chickenpox, with the hope that it will give patients more control of their health and care and relieve pressure on GPs.

“The public need to be able to get reliable information about their health easily and in ways they actually use,” said Matthew Gould, chief executive of NHSX. “By working closely with Amazon and other tech companies, big and small, we can ensure that the millions of users looking for health information every day can get simple, validated advice at the touch of a button or voice command,” Gould added.

WHY IT MATTERS

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Professor Helen Stokes-Lampard, chair of the Royal College of GPs (RCGP), said the initiative had “potential” to support patients and free up GP appointments.

But the RCGP chair also cautioned that many people would not be able to afford the device, which could result in “widening health inequalities and making access to care even harder for some of the most vulnerable people in our society”.

“Technology can be brilliant, when used appropriately, and it is playing an increasingly important part in the way we deliver care to our patients throughout the NHS, but we must be careful not to create a ‘digital divide’ between those patients who can afford it and are able to use it, and those who can’t,” Professor Stokes-Lampard added.

THE LARGER TREND

In the US, Amazon announced in May that it would allow developers to create HIPAA-compliant healthcare skills for Alexa through an invite-only programme.

A month before, however, Bloomberg News reported that an Amazon team was employed to review recordings from its smart speakers as part of efforts to train systems and further develop services.

An Amazon spokesperson told the publication at the time: “We have strict technical and operational safeguards, and have a zero tolerance policy for the abuse of our system. Employees do not have direct access to information that can identify the person or account as part of this workflow. All information is treated with high confidentiality and we use multi-factor authentication to restrict access, service encryption and audits of our control environment to protect it.”

ON THE RECORD

Commenting on the partnership, Matt Hancock, health and social care secretary, said: “We want to empower every patient to take better control of their healthcare and technology like this is a great example of how people can access reliable, world-leading NHS advice from the comfort of their home, reducing the pressure on our hardworking GPs and pharmacists.

“Through the NHS Long Term Plan, we want to embrace the advances in technology to build a health and care system that is fit for the future and NHSX will drive this revolution to bring the benefits to every patient, clinician and carer.”

Date: July 16, 2019

Source: DistilNFO

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • ClearPoint Neuro, Inc. Announces License and Research Agreement with PhilipsClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
  • Premier Health Announces Binding LOI to Acquire Cloud Practice Inc., a National Medical Software Application CompanyPremier Health Announces Binding LOI to Acquire Cloud Practice Inc., a National Medical Software Application Company
  • Verily & L’Oreal Launches Diverse Skin and Hair Health Registry.Verily & L’Oreal Launches Diverse Skin and Hair Health Registry.
  • The Future of Healthcare: 3 Predictions for the Next Five YearsThe Future of Healthcare: 3 Predictions for the Next Five Years
  • Orion Acquires Inovet’s Animal Health BusinessOrion Acquires Inovet’s Animal Health Business
  • Cresco Labs to Acquire Tryke Including the ReefDispensary Portfolio – Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale CapabilitiesCresco Labs to Acquire Tryke Including the ReefDispensary Portfolio – Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale Capabilities
  • Variantyx Nabs $41.1M for Tech-Backed Genomic AnalysisVariantyx Nabs $41.1M for Tech-Backed Genomic Analysis
  • Neogen acquires Canadian animal genomics laboratoryNeogen acquires Canadian animal genomics laboratory

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications